IGF-1 levels in turn suppress the activation of endothelial cell proliferation by VEGF, leading to an arrest in the growth of blood vessels that is typical of phase I ROP pathogenesis [31,35]. This evidence concerns the gene IGF1 and retinopathy of prematurity.